Corrigendum to “Seroprevalence and durability of rubella virus antibodies in a highly immunized population”. [Vaccine 37 (2019) 3876–3882] (Vaccine (2019) 37(29) (3876–3882), (S0264410X19306735), (10.1016/j.vaccine.2019.05.049))

The authors regret that the previously published Acknowledgements were incomplete. They are reproduced in full below: AcknowledgmentsWe would like to thank the staff of the Mayo Clinic Vaccine Research Group and all of the participants in this study. We would also like to thank Emily A. Voigt for the assessment of rubella antibody titers and the initial analysis identifying low and high responders to rubella. We thank Caroline L. Vitse for editorial assistance with the preparation of this manuscript. The work reported was funded by the National Institutes of Health under Award Number R37AI048793. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The Mayo Clinic Biobank was supported by funding from the Mayo Clinic Center for Individualized Medicine. The authors would like to apologise for any inconvenience caused.